- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Environmentally-Friendly
Global Pharmaceuticals & Biotech Environmentally-Friendly
UPDATED Jun 17, 2023
Investing in companies that think about the future will generate eco-friendly products and sustainable returns. As consumers become more environmentally-aware, demand will increase for these companies' products.
3,138 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BIOA BBioArctic | kr346.20 | -2.8% | 378.8% | kr30.5b | kr395.20 | PE93.4x | E36.7% | 0% | ||
| ITCIIntra-Cellular Therapies | US$63.95 | -2.8% | 16.4% | US$6.1b | US$76.50 | PS19.7x | E64.6% | n/a | ||
| A216080JETEMA | â‚©19,220.00 | 2.0% | 26.4% | â‚©342.6b | â‚©30,000.00 | PS6.9x | E93.5% | n/a | ||
| 688356Jenkem Technology | CNÂ¥114.00 | 4.7% | -48.2% | CNÂ¥6.9b | CNÂ¥175.50 | PE37.9x | E28.5% | 0.8% | ||
| 300841Chengdu Kanghua Biological Products | CNÂ¥68.42 | -7.0% | -27.7% | CNÂ¥9.2b | n/a | PE16.1x | E32.1% | 0.7% | ||
| IMMUMendus | kr0.58 | -19.9% | -73.9% | kr117.8m | kr4.70 | PS86x | E76.3% | n/a | ||
| SANNSanthera Pharmaceuticals Holding | CHF0.91 | -3.2% | -13.0% | CHF96.0m | CHF13.60 | PS12.8x | E60.2% | n/a | ||
| STXShield Therapeutics | UK£0.067 | -0.7% | -51.3% | UK£47.8m | n/a | PS10.7x | E96.6% | n/a | ||
| CTICCTI BioPharma | US$9.07 | 0.2% | 48.0% | US$1.2b | US$10.49 | PS15.8x | E59.0% | n/a | ||
| FOLDAmicus Therapeutics | US$13.09 | 2.2% | 40.0% | US$3.7b | US$15.80 | PS11.1x | E63.6% | n/a | ||
| 688621Beijing Sun-Novo Pharmaceutical Research | CNÂ¥61.70 | 3.5% | -13.6% | CNÂ¥6.9b | n/a | PE40.5x | E32.4% | 0.7% | ||
| PARParadigm Biopharmaceuticals | AU$0.92 | 1.7% | -8.0% | AU$259.5m | AU$2.70 | PS6700.2x | E102.2% | n/a | ||
| 4147TaiMed Biologics | NT$96.60 | -8.4% | 54.3% | NT$24.4b | NT$153.23 | PS41.1x | E92.6% | n/a | ||
| FYBFormycon | €67.30 | -4.8% | -9.1% | €1.1b | €118.67 | PE30x | E27.1% | n/a | ||
| 300705Hunan Jiudian Pharmaceutical | CNÂ¥26.63 | -4.9% | 42.6% | CNÂ¥9.2b | n/a | PE31.6x | E27.5% | 0.9% | ||
| TLXTelix Pharmaceuticals | AU$11.41 | 11.0% | 181.0% | AU$3.6b | AU$11.82 | PS22.7x | E51.1% | n/a | ||
| ULTIUltimovacs | kr78.30 | -0.5% | 19.9% | kr2.7b | kr164.50 | PB6.4x | E61.7% | n/a | ||
| NWRNNewron Pharmaceuticals | CHF4.60 | 8.2% | 217.2% | CHF82.1m | CHF10.44 | PS13.8x | E56.2% | n/a | ||
| ALONCOncodesign Société Anonyme | €14.42 | 0% | 57.3% | €99.4m | €18.64 | PS3x | E101.2% | n/a | ||
| AETHERAether Industries | ₹997.45 | -1.0% | 29.4% | ₹124.2b | ₹1,070.00 | PE95.2x | E30.9% | n/a | ||
| 688046GemPharmatech | CNÂ¥20.75 | -3.7% | -32.0% | CNÂ¥8.5b | n/a | PE51.4x | E28.2% | 0.2% | ||
| LGPLittle Green Pharma | AU$0.17 | 0% | -29.2% | AU$50.6m | n/a | PS2.6x | E140.5% | n/a | ||
| 688131Shanghai Haoyuan Chemexpress | CNÂ¥60.79 | 3.6% | -34.6% | CNÂ¥9.1b | CNÂ¥101.43 | PE51.4x | E40.3% | 0.4% | ||
| 301207Hualan Biological Bacterin | CNÂ¥34.00 | -6.0% | 6.3% | CNÂ¥20.4b | CNÂ¥40.69 | PE33.2x | E30.1% | 0.6% |